Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

CEO and President Shaff Eric D. converted options into 7,812 shares and sold $1,355 worth of shares (2,505 units at $0.54), increasing direct ownership by 3% to 170,389 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.